2006
DOI: 10.4103/0253-7613.19846
|View full text |Cite
|
Sign up to set email alerts
|

Screening of antimalarial drugs: An overview

Abstract: Department of Pharmacology, Efforts to discover and develop new antimalarial drugs have increased dramatically in recent Maulana Azad Medical College, years mainly because of resistance to existing antimalarial drugs. Selection of candidate drugs Bahadur Shah Zafar Marg, for clinical trials in man and the design of clinical protocols are based upon consideration of Delhi-110002. data from a battery of preclinical test systems. All compounds are assessed initially in one or *Malaria Research Center, more primar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
110
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(110 citation statements)
references
References 38 publications
0
110
0
Order By: Relevance
“…Untreated control mice typically die approximately 1 week after infection 15 . For treated mice the survival time (in days) was recorded and the mean survival time was calculated in comparison with that of the negative control group 16 .…”
Section: In Vivo Anti-malarial Activitymentioning
confidence: 99%
“…Untreated control mice typically die approximately 1 week after infection 15 . For treated mice the survival time (in days) was recorded and the mean survival time was calculated in comparison with that of the negative control group 16 .…”
Section: In Vivo Anti-malarial Activitymentioning
confidence: 99%
“…Moreover, control and treatment of these Plasmodium infections have been complicated as widespread resistance to the available antimalarial drugs such as chloroquine (Kalra et al 2006). So there is an urgent requirement for the search of alternative antimalarials to combat the resistance of the existing antimalarial drugs.…”
Section: Introductionmentioning
confidence: 99%
“…This was carried out using the Peter's 4-day suppressive test (Kalra et al, 2006). On day 0, the parasitemia and red blood cell count of the donor mice was determined by using a Giemsa-stained thin blood smear and an improved Neubauer counting chamber, respectively.…”
Section: In Vivo Schizontocidal Activitymentioning
confidence: 99%